News – Page 418 – Endpoints News

Wave Life Sciences to receive $170M upfront in new partnership with GSK to develop a large number of candidates

3 years ago

Researchers call for using more than surrogate outcomes to approve new antibiotics

3 years ago

MarketingRx roundup: Pfizer teams with NFL player for sickle cell awareness; Astellas crowdsources patient solutions

3 years ago

#ASH22: Novartis PNH drug tops AstraZeneca with what's described as 'practice-changing' potential

3 years ago

#ASH22: BeiGene's BTK inhibitor shows superiority to AbbVie, J&J blockbuster in PFS

3 years ago

Chris Garabedian's Xontogeny shepherds two more companies through $60M Series A rounds

3 years ago

Abbott heads up new advocacy effort for concussion awareness with spokesperson, actress Rebel Wilson

3 years ago

Updated: Moderna claims cancer vaccine success in trial of mRNA shot with Merck

3 years ago

Flagship plants next bet on chronic diseases with ex-Ancestry CEO at the helm

3 years ago

Paul McKenzie to take the reins of CSL as new CEO in March

3 years ago

Updated: FDA approves Mirati's KRAS drug in non-small cell lung cancer

3 years ago

#ASH22: Regeneron claims it has set a 'new benchmark' in follicular lymphoma

3 years ago

Seagen rolls out data for Adcetris combination to treat Hodgkin lymphoma

3 years ago

WIB22: Hear from our 2022 Women in Biopharma R&D honorees, and catch our panel on empowering women

3 years ago

Sanofi teams up science and sports for Paris 2024 Olympics sponsorship, extending its #WeNeverSettle ethos

3 years ago

Clinical trial branding? Biotechs and pharmas migrate name and identity strategies even earlier

3 years ago

ImmunityBio looks to pull in $157M from founder Patrick Soon-Shiong and another investor

3 years ago

Black Diamond spins out antibody work into new biotech with $30M from Versant, NEA

3 years ago

Vertex, Moderna prepare to take their inhaled mRNA cystic fibrosis drug into the clinic

3 years ago

#ASH22: ALX Oncology reports complete response with anti-CD47 candidate in combo trial

3 years ago

#ASH22: Lilly’s Loxo rounds out the PhI/II data for lymphoma drug under FDA review

3 years ago

#ASH22: Cogent touts data on small subset of rare disease patients in bid to compete with Blueprint

3 years ago

GSK chief Emma Walmsley picks out a trim new global HQ in downsizing move

3 years ago

Clovis files for bankruptcy, will keep operating and plans to sell pipeline asset to Novartis

3 years ago

First page Previous page 415 416 417418419 420 421 Next page Last page